Amphetamine Addiction Clinical Trial
Official title:
Treatment Efficacy in Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder
The investigators will conducted a randomized double-blind placebo-controlled study to investigate the treatment outcomes of add-on low dose dextromethorphan (DM), memantine (MM), or dextromethorphan and memantine combination (DM+MM) in amphetamine-type stimulants use disorder patients.
The investigators will conducted a randomized double-blind placebo-controlled study to investigate the treatment outcomes of add-on low dose dextromethorphan (60mg/day, DM), memantine (5 mg/day, MM), or dextromethorphan (60mg/day) and memantine (5mg/day) combination (DM+MM) in amphetamine-type stimulants use disorder patients. The investigators will recruit 120 patients with ATSUD in three years and allocate participants to add-on DM, MM, DM+MM or placebo group in a 1:1:1:1 ratio (participants will also undergo usual psychosocial interventions).The investigators will follow up the participants for 12 weeks and measure the treatment responses, urine drug tests, craving scales and side effects to evaluate the therapeutic effects of add-on DM, MM, or DM+MM. Neuropsychological assessments, tests for inflammatory parameters and neurotrophic factors, and brain functional magnetic resonance imaging (fMRI) will also be evaluated during 12-weeks follow up. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Not yet recruiting |
NCT02836756 -
Cannabidiol as a New Intervention for Amphetamine Dependence
|
Phase 2 | |
Completed |
NCT03318081 -
The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction
|
N/A | |
Completed |
NCT03221283 -
The Application of Music Therapy in Female Amphetamine Use Disorder
|
N/A | |
Withdrawn |
NCT02952196 -
Cannabioids as a New Intervention for Amphetamine Dependence
|
Phase 2 | |
Completed |
NCT02285556 -
The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus
|
N/A | |
Completed |
NCT02713815 -
Novel Intervention for Amphetamine-type Stimulants Addiction
|
N/A | |
Completed |
NCT00713479 -
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
|
Phase 1 | |
Completed |
NCT04993300 -
Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction
|
N/A | |
Completed |
NCT02950376 -
The Novel Addiction Assessment Study in Synthetic Drugs Addiction
|
||
Recruiting |
NCT04531384 -
Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.
|
N/A |